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Abstract
Magnetisation transfer (MT) imaging of the central nervous system has provided further
insight into the pathophysiology of neurological disease. However, the use of this method to
study the lower spinal cord has been technically challenging, despite the important role of
this region, not only for motor control of the lower limbs, but also for the neural control of
lower urinary tract, sexual and bowel functions. In this study, the feasibility of obtaining reli-
able grey matter (GM) and white matter (WM) magnetisation transfer ratio (MTR) measure-
ments within the lumbosacral enlargement (LSE) was investigated in ten healthy volunteers
using a clinical 3T MRI system. The mean cross-sectional area of the LSE (LSE-CSA) and
the mean GM area (LSE-GM-CSA) were first obtained by means of image segmentation
and tissue-specific (i.e. WM and GM) MTRmeasurements within the LSE were subse-
quently obtained. The reproducibility of the segmentation method and MTRmeasurements
was assessed from repeated measurements and their % coefficient of variation (%COV).
Mean (± SD) LSE-CSA across 10 healthy subjects was 59.3 (± 8.4) mm2 and LSE-GM-CSA
was 17.0 (± 3.1) mm2. The mean intra- and inter-rater % COV for measuring the LSE-CSA
were 0.8% and 2.3%, respectively and for the LSE-GM-CSA were 3.8% and 5.4%, respec-
tively. Mean (± SD) WM-MTR was 43.2 (± 4.4) and GM-MTR was 40.9 (± 4.3). The mean
scan-rescan % COV for measuring WM-MTR was 4.6% and for GM-MTR was 3.8%. Using
a paired t-test, a statistically significant difference was identified betweenWM-MTR and
GM-MTR in the LSE (p<0.0001). This pilot study has shown that it is possible to obtain reli-
able tissue-specific MTR measurements within the LSE using a clinical MR system at 3T.
The MTR acquisition and analysis protocol presented in this study can be used in future
investigations of intrinsic spinal cord diseases that affect the LSE.
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Introduction
Neurological disorders affecting the spinal cord (SC) can involve either the grey matter (GM),
white matter (WM) or both. Conditions such as multiple sclerosis (MS), amyotrophic lateral
sclerosis (ALS) and neuromyelitis optica affect both tissue types [1–3], whereas certain leuko-
dystrophies affect the WM tracts only [4, 5]. Imaging tools that offer reliable assessment of tis-
sue-specific (i.e. GM andWM) pathological involvement in the SC have potential to be helpful
in the differential diagnosis, and also in monitoring the course and guiding the treatment, of
such neurological conditions.
Magnetisation transfer (MT) imaging is a quantitative magnetic resonance imaging method
(qMRI), which can be used in the central nervous system to study the interaction between
restricted protons (i.e. protons bound to macromolecules) and free protons [6–8]. Ex vivo
investigations have previously shown that the magnetisation transfer ratio (MTR) correlates
with tissue myelin content and, less strongly, with axonal density in the brain [9] and spinal
cord [10]. Normal regional variations in MTR have been reported in the adult brain [11–13],
in normal aging [14] and the upper spinal cord [15, 16] in vivo. Significant reductions in MTR
values, as compared to healthy controls, have been reported in the upper SC in cases of ALS
[17], MS [18–20] and spinal cord injury (SCI) [21, 22], with significant correlations identified
between the MTR measures and common measures of sensory and motor dysfunction.
Whilst MTR measurements in the upper SC have already provided insight into the patho-
physiology of certain neurological conditions [17–22], to date there are no clinical studies
reporting such changes in the lower SC. This region plays quite an important role not only for
motor control of the lower limbs, but also for the neural control of lower urinary tract (LUT),
sexual and bowel functions [23]. Recently, a new MRI method has been presented, which reli-
ably identifies the widest cross-section of the lower SC (i.e. the lumbosacral enlargement; LSE)
and proposes this as an intrinsic imaging biomarker in the study of neurological disease involv-
ing the SC [24]. Whilst the method has been shown to offer reliable GM andWM cross-sec-
tional area (CSA) measurements within the LSE, its utility in terms of facilitating tissue-
specific qMRI investigations such as MTR is yet to be explored.
In this pilot study, the feasibility of obtaining tissue-specific MTR measurements within the
LSE was investigated for the first time by utilising the detailed structural information obtain-
able with the previously reported method [24], while at the same time addressing the technical
challenges associated with MTR measurements at that level to provide a reliable and clinically
viable index sensitive to myelin content in the lower SC.
Materials and Methods
Study Participants
Ten healthy volunteers (4 male and 6 female, mean age 28 years; range 26–35 years) were
recruited for this study, with five of these returning for a repeat scan. Written informed consent
was obtained from all study participants and the work was approved by the National Hospital
for Neurology and Neurosurgery and the Institute of Neurology Joint Research and NRES
committee London Bloomsbury (Formally, London REC2 Ethics Committee).
MR Imaging
A 3T Philips Achieva MRI system with radiofrequency (RF) multi-transmit technology (Phil-
ips Healthcare, Best, Netherlands) and the manufacturer’s product 16-channel neurovascular
coil and 15-channel SENSE spine coil were used. A 2D fast-spin echo (FSE) T2-weighted refer-
ence scan of the thoraco-lumbar spine was first obtained in the sagittal plane and used to
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facilitate planning of subsequent high-resolution structural and MTR acquisitions perpendicu-
lar to the longitudinal axis of the SC.
For GM andWM segmentation within the LSE, a high-resolution acquisition was pre-
scribed in the axial-oblique plane (i.e. perpendicular to the cord) through the T11—L1 verte-
bral level, to ensure coverage of the LSE in all cases as previously demonstrated [24, 25]
(Fig 1). For this, a 3D slab-selective fast field echo (3D-FFE) sequence was used with fat sup-
pression and the following imaging parameters: TR = 22 ms, TE = 4.4 ms, flip angle α = 10°,
FOV = 180 x 180 mm; voxel size = 0.5 x 0.5 x 5 mm3; NSA = 8, slices = 19; slice gap = 0. The
scan time for this acquisition was approximately 19 minutes.
MTR imaging was performed using identical scan geometry to the structural acquisition
with the following parameters: 3D slab-selective FFE with two echoes (TR / TE1 / TE2 = 36 /
1.69 / 3.1 ms; flip angle α = 10°), with and without Sinc—Gaussian shaped MT saturation
pulses with nominal α = 360°; offset frequency = 1 KHz, and duration 16 ms; number of
slices = 45; FOV = 180 x 180 mm; acquisition matrix = 240 x 240 mm; voxel size = 0.75 x 0.75 x
5 mm3 (reconstructed voxel size in-plane = 0.5 x 0.5 mm). MTR data were acquired using a
radial acquisition profile with the fold-over direction set in the foot/head (FH) direction [26].
The acquisition time for the MTR sequence was approximately 20 mins and the total scan time
for the entire imaging protocol was approximately 45 mins.
Participants were positioned in the MRI scanner in such way to ensure close contact of the
lower back with the flat surface of the spine coil to maximise the signal-to-noise ratio (SNR).
Fig 1. Prescription of the imaging volume between T11-L1 vertebral level to ensure coverage of the
lumbosacral enlargement (LSE). Red arrow shows the position of the widest section of the LSE within the
volume in this particular case.
doi:10.1371/journal.pone.0134495.g001
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This was achieved by elevating the legs using a triangular foam pad providing support under
the knees; this ensured that the curvature of the lumbar spine was reduced thereby minimizing
the gap between the lumbar spine and the spine coil. Furthermore, a strap fastened around a
small rectangular pad was used across the abdomen to facilitate even closer contact with the
spine coil, yet without causing any discomfort.
Image Analysis Protocol
Using the linear registration toolkit in FSL (http://www.fmrib.ox.ac.uk/fsl/) with schedule file
‘sch2D_6dof’ and all other options set to default, the MT-off and MT-on volumes were co-reg-
istered independently to the 3D-FFE high-resolution structural scan, prior to calculation of the
MTR-map; this was necessary since the MT-on and MT-off images were not acquired inter-
leaved therefore motion could have occurred between the two scans, and also to account for
possible changes in the cord position between the acquisition of the 3D-FFE sequence and the
MT-on and MT-off data. Mean CSA and MTR measurements were obtained from a 15 mm
section (i.e. 3 slices) through the widest segment of the LSE as follows [24]: using the active sur-
face model (ASM) segmentation method in JIM 6.0 (Xinapse systems, www.xinapse.com) [27],
seed points were manually positioned in the centre of the cord on each slice of the 3D-FFE
structural scan and the cord area was identified and recorded. The slice with the largest CSA
was subsequently selected along with the two adjacent slices in order to calculate the mean
LSE-CSA for that section (Fig 2A). From the same section, GM was segmented using JIM 6.0
and the mean area (LSE-GM-CSA) was calculated as previously described [24] (Fig 2B).
Binary masks of GM andWMwere obtained (the WMmask was generated by subtracting
the GMmask from the total cord mask) and applied to the MTR map to calculate mean MTR
values within GM (GM-MTR) and white matter (WM-MTR) (Fig 2C). In order to ensure that
GM- and WM-MTR were not significantly affected by partial volume—i.e. cerebrospinal fluid
(CSF) contamination, inaccuracies at the WM and GM boundaries and possible subtle registra-
tion errors—the WM and GMmasks were first eroded using FSL (S1 Fig).
Reproducibility Assessment
The reproducibility of the MTR parameters was assessed by performing a ‘scan-rescan test’ on
five out of ten healthy volunteers with a minimum of seven days (and a maximum of 14 days)
in between the first and the second visits. One experienced rater analysed all the data. In order
to demonstrate the intra-rater reproducibility of the GM andWM segmentation method, the
same rater re-analysed all the data from the 5 volunteers’ first visit twice; the analysis was per-
formed on separate occasions with a minimum of 1 week between each analysis. Inter-rater
reproducibility was assessed by employing a second rater to analyse the data from the 5 volun-
teers’ first visit. The two raters were unaware of the results of each other.
Fig 2. A) Cord cross-sectional area (CSA) contour identified using the active surface model tool
(ASM) B) GM area contour identified usingmanual segmentation. C) CSA and GM area contours are
shown overlaid onto the MTR-map following linear co-registration.
doi:10.1371/journal.pone.0134495.g002
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Statistical Analysis
For the scan-rescan assessment of the MTR acquisition and the intra- and inter-rater re-
producibility of the segmentation method, the coefficient of variation (COV) was calculated
using the mean and standard deviation from the repeated measures and the equation COV =
[SD/mean] × 100%. The intra-rater segmentation results were further evaluated using the Dice
similarity coefficient (DSC) [24, 28].
Possible differences in MTR values between GM andWMwere assessed using a paired
t-test, after checking the normality of the data. Statistical significance was accepted at p<0.05.
Results
Mean (± SD) LSE-CSA of the 15 mm section studied (i.e. 3 slices) across 10 healthy subjects
was 59.3 (± 8.4) mm2 and mean (± SD) LSE-GM-CSA was 17.0 (± 3.1) mm2. The mean intra-
and inter-rater % COV for measuring the LSE-CSA were 0.8% and 2.3%, respectively and for
measuring the LSE-GM-CSA were 3.8% and 5.4%, respectively. Mean (± SD) DSC for a single
rater (intra-rater) of the LSE-CSA was 0.98 (± 0.01) and of the LSE-GM-CSA was 0.92 (± 0.01).
Tissue-specific MTR values within these volumes were determined from the calculated
MTR maps. Mean (± SD) WM-MTR was 43.2 (± 4.4) and the mean (± SD) GM-MTR was
40.9 (± 4.3). The mean scan-rescan % COV for the WM-MTR was 4.6% and for the GM-MTR
was 3.8%. A paired t-test showed a statistically significant difference between the WM-MTR
and GM-MTR (p<0.0001).
Table 1 summarizes the main results of the study. Fig 3 shows a stacked plot diagram of tis-
sue-specific CSA measurements in all 10 healthy subjects. S1 Dataset contains all the raw data
for the study.
Table 1. Cross-sectional area (CSA) andmagnetisation transfer ratio (MTR) measurements in the lumbosacral enlargement (LSE) of 10 healthy
subjects.
Measurement Mean SD Scan-rescan (%COV) Intra-rater (%COV) Inter-rater (%COV) DSC
LSE-CSA (mm2) 59.3 8.4 - 0.8 2.3 0.98
LSE-GM-CSA (mm2) 17.0 3.1 - 3.8 5.4 0.92
WM-MTR 43.2 4.4 4.6 0.8 0.9 -
GM-MTR 40.9 4.3 3.8 0.4 0.8 -
Abbreviations:- LSE-CSA: Lumbosacral enlargement cross-sectional area; LSE-GM-CSA: Lumbosacral enlargement grey matter cross-sectional area;
WM-MTR: White matter magnetisation transfer ratio, GM-MTR: Grey matter magnetisation transfer ratio; DSC: Dice similarity coefﬁcient.
doi:10.1371/journal.pone.0134495.t001
Fig 3. Stacked plot diagram showing grey matter (GM) and white matter (WM) mean area fractions
measured in a 15mm section through the lumbosacral enlargement (LSE) in 10 healthy subjects.
doi:10.1371/journal.pone.0134495.g003
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Discussion
In this study, the feasibility of obtaining tissue-specific (i.e. GM andWM) MTR measurements
within the LSE was investigated for the first time using a commercially available 3T MR system,
software and hardware and by addressing a number of technical considerations. To obtain tis-
sue-specific quantitative measurements within the lower SC, first a reliable way to depict these
tissue types was essential. Based on a recently published report, high-resolution images of the
LSE were acquired within the MTR imaging protocol and thereafter used for image segmenta-
tion [24]. The effectiveness of the segmentation method was evaluated and the results were
found to be in agreement with the previous report, with favorable intra-rater COV values of
3.8% for measuring the LSE-GM-CSA and 0.8% for the LSE-CSA, as compared to 8% and 2%,
respectively. Inter-rater COV values were also in agreement with 5.4% for measuring the
LSE-GM-CSA and 2.3% for the LSE-CSA, as compared to 8.6% and 2.5%, respectively. In addi-
tion, the DSC of the LSE-CSA and LSE-GM-CSA in this study were 0.98 and 0.92, respectively
as compared to 0.97 and 0.89, respectively in the previous report. These results confirmed the
reliability of the segmentation method, which was subsequently used to facilitate the tissue-spe-
cific MTR measurements in this study.
The MTR acquisition was set up with imaging parameters to match the structural acquisi-
tion as closely as possible, albeit with some necessary modifications. Due to SNR restrictions, it
was not possible to achieve identical in-plane resolution to the structural scan (i.e. 0.5 x 0.5
mm2), requiring post-acquisition interpolation (i.e. in k-space) of the data acquired at a 0.75 x
0.75 mm2 resolution. SNR restrictions may be addressed either by using a larger voxel size, lon-
ger acquisition times or with the use of dedicated RF coil designs, but such options were either
unsuitable or unavailable in this particular case. Furthermore, the physiological motion arising
from major blood vessels, the kidney and the bowel function, often requires the use of regional
saturation (REST) slabs to compensate. However, such measures of physiological motion-
related image artifact reduction involve the use of additional RF pulses within the pulse
sequence, with concomitant negative effects on the measurable MTR. To partly account for
this, the MTR sequence was used with a radial acquisition profile and the fold-over direction
set in the foot/head (FH), therefore alleviating the need for REST slabs. However, using radial
acquisitions, aliasing artifacts are often encountered and must be accounted for whenever pos-
sible. For this reason, a much larger imaging volume was used than the anatomical region of
interest, and the edge slices that were affected the most were subsequently discarded. Of course,
this also meant that the scanning time was increased and future pulse sequence developments
should try to address such limitation. Additional sources of physiological motion-related arti-
facts in spinal cord imaging may include CSF pulsation, though less concerning in this case
considering the amplitude of pulsation is considerably lower in the lumbar spine than in the
cervical and thoracic spine [29, 30].
In this study, the high resolution structural and MTR acquisition protocol for studying the
LSE was optimized using a clinical 3T MR system. Higher magnetic field offers better SNR and
enables more efficient acquisition with improved conspicuity of structures than lower magnetic
field MR systems [31, 32]. In the spinal cord, the potential for higher resolution imaging is par-
ticularly important considering the small size of the structure and the poorly defined boundary
between GM andWM. The use of lower magnetic field systems to obtain similar measure-
ments as in this study would require considerably longer scan time and possibly extending
beyond clinically acceptable times. However, in applications where such high resolution is not
required, excellent image contrast and reliable MTR measurements may be obtained by using
both high and low magnetic field MR systems [31].
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The structural images were co-registered with the MTR maps using linear registration, first
by registering the MT-off and MT-on volumes independently to the structural scan, prior to
calculation of the MTR-map. Despite matching the imaging parameters of the acquisitions as
closely as possible, it is likely that the use of a radial acquisition profile for MTR imaging may
have hampered the registration process due to the differences in data reconstruction between
Cartesian and radial profiles [26]. Nevertheless, to partly account for such potential inaccura-
cies, the GM andWMmasks were eroded prior to the calculation of MTR values and therefore
such effects, as well as CSF contamination and inaccuracies at the WM and GM boundaries,
are unlikely to have confounded the measurements considerably.
In this study, in vivoWM-MTR and GM-MTR normative values in 10 volunteers measured
from the total volumes extracted from a 15 mm section of the LSE are reported for the first
time. The significant difference in MTR values observed between GM andWM (p<0.0001), is
likely to reflect a difference in myelin content between these tissue types. However, the absolute
MTR measure reflects a complex combination of various biological factors and is also highly
sequence- and MR system-dependent, therefore the MTR values obtained in this study cannot
be directly compared with those obtained using a different sequence or at another centre.
Quantitative MT (qMT) imaging provides more fundamental parameters relating to tissue
structure and future investigations using this technique may allow further insight into differ-
ences between GM andWM in the lower SC.
Obtaining tissue-specific MTR measurements within the LSE may have potential clinical
applications in the evaluation of patients where a lower SC lesion is suspected. Spinal cord
injury [33–38], and MS [39, 40] may affect the lower SC, resulting in lower limb weakness and
LUT, sexual and bowel dysfunction. In neurodegenerative conditions such as multiple system
atrophy (MSA) selective degeneration occurs in the lower SC, specifically the Onuf’s and para-
sympathetic nuclei of the sacral cord resulting in urinary retention and changes of reinnerva-
tion in the anal sphincter muscle as detected by concentric needle EMG [41, 42]. Ex vivo
investigations have provided evidence of somatic and motor neurons loss in the lower SC in
MSA [43], and pathology in the LSE is probably the main cause of LUT dysfunction. However,
it is not possible using the current protocol to identify with certainty the regions of the LSE
from which the somatic, parasympathetic and sympathetic innervation for the LUT arise [23].
Routine clinical MRI sequences are often insensitive to detect such changes however, and the
use of quantitative imaging measures in the lower SC (LSE) would help to evaluate intrinsic
pathological abnormalities in vivo with the potential for clinical applications.
Some of the limitations of the present study, both in terms of image acquisition and analysis,
have already been mentioned. However, when evaluating these methods in the context of clini-
cal utility, additional obstacles may be considered that have not been encountered in this pilot
study of healthy volunteers. In terms of the acquisition, the long scans required to depict GM/
WM and obtain reliable MTR measurements within the LSE may result in image artifacts due
to involuntary patient motion; for this reason, particular attention to the immobilization tech-
nique is required, especially in neurological conditions which are associated with involuntary
lower limb movement. The MTR acquisition presented in this study may benefit from further
refinement in the future in order to reduce the acquisition time by employing more efficient
coverage of smaller anatomical regions such as the LSE. In terms of image analysis, the pres-
ence of lesions or atrophy in the spinal cord may impose further challenges, such as difficulties
in GM/WM segmentation and subsequent MTR measurements; in addition, the COV values
observed in healthy volunteers for segmenting GM in the LSE will certainly affect the ability to
detect subtle changes in disease state therefore this method may require a large sample size or
to asses damage that has progressed considerably. Future work will therefore be directed at
reducing (or removing altogether) operator input, for example through the use of lumbar
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spinal cord templates, or other fully-automated image analysis methods depending on the spe-
cific application.
In summary, the results of this study show that it is possible to obtain in vivo tissue-specific
MTR measurements within the LSE using a clinical MR system at 3T. This pilot study provides
a solid foundation for future investigative studies involving patients with neurological disorders
affecting the LSE region of the SC.
Supporting Information
S1 Dataset. Raw data.
(XLSX)
S1 Fig. A) Example of grey matter segmentation (contour shown in red) B) pixels within
grey matter with minimal or no partial volume (green points) maybe used to calculate
MTR.
(TIFF)
Acknowledgments
This work and the NMR Research Unit are supported by the Multiple Sclerosis Society of
Great Britain and Northern Ireland and the Department of Health’s Comprehensive Biomedi-
cal Research Centre at University College Hospitals Trust.
Author Contributions
Conceived and designed the experiments: CU RS CWMY. Performed the experiments: CU RS
MLMY. Analyzed the data: CUMYML. Contributed reagents/materials/analysis tools: MY JP
DM CW.Wrote the paper: CU RS ML JP DM CWMY.
References
1. Gilmore CP, Bö L, Owens T, Lowe J, Esiri MM, Evangelou N (2006) Spinal cord gray matter demyelin-
ation in multiple sclerosis—a novel pattern of residual plaque morphology. Brain Pathol 16:202–208.
PMID: 16911477
2. Tsukagoshi H, Yanagisawa N, Oguchi K, Nagashima K, Murakami T (1979) Morphometric quantifica-
tion of the cervical limb motor cells in controls and in amyotrophic lateral sclerosis. J Neurol Sci
41:287–297. PMID: 438856
3. Jarius S, Wildemann B (2010) AQP4 antibodies in neuromyelits optica: diagnostic and pathogenetic rel-
evance. Nat Rev Neurol 6:383–392. doi: 10.1038/nrneurol.2010.72 PMID: 20639914
4. Schiffmann R, van der Knaap MS (2009) Invited article: an MRI-based approach to the diagnosis of
white matter disorders. Neurology 72:750–759. doi: 10.1212/01.wnl.0000343049.00540.c8 PMID:
19237705
5. Labauge P (2009) Magnetic resonance findings in leucodystrophies and MS. Int MS J 16:47–56.
PMID: 19671368
6. Wolff SD, Balaban RS (1989) Magnetization transfer contrast (MTC) and tissue water proton relaxation
in vivo. Magn Reson Med 10:135–144. PMID: 2547135
7. Fralix TA, Ceckler TL, Wolff SD, Simon SA, Balaban RS (1991) Lipid bilayer and water proton magneti-
zation transfer effect of cholesterol. Magn Reson Med 18:214–223. PMID: 2062233
8. Henkelman RM, Stanisz GJ, Graha GJ (2001) Magnetization transfer in MRI: a review. NMR Biomed
14:57–64. PMID: 11320533
9. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH (2004) Magnetization transfer ratio and
myelin in postmortem multiple sclerosis brain. Ann Neurol 56:407–415. PMID: 15349868
10. Bot JC, Blezer EL, Kamphorst W, Lycklama A Nijeholt GJ, Ader HJ, et al (2004) The spinal cord in multi-
ple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic
results. Radiology 233:531–540. PMID: 15385682
In VivoMTRMeasurements in the Lumbosacral Enlargement
PLOS ONE | DOI:10.1371/journal.pone.0134495 July 31, 2015 8 / 10
11. Mehta RC, Pike GB, Enzmann DR (1995) Magnetization transfer MR of the normal adult brain. AJNR
Am J Neuroradiol 16:2085–91. PMID: 8585499
12. Garcia M, Gloor M, Bieri O, Wetzel SG, Radue EW Scheffler K (2011) MTR variations in normal adult
brain structures using balanced steady-state free precession. Neuroradiology 53:159–67. doi: 10.
1007/s00234-010-0714-5 PMID: 20480154
13. Sled JG, Levesque I, Santos AC, Francis SJ, Narayanan S, Brass SD, et al (2004). Regional variations
in normal brain shown by quantitative magnetization transfer imaging. Magn Reson Med 51:299–303.
PMID: 14755655
14. Callaghan MF, Freund P, Draganski B, Anderson E, Cappelletti M, Chowdhury R, et al (2014) Wide-
spread age-related differences in the human brain microstructure revealed by quantitative magnetic
resonance imaging. Neurobiol aging 35:1862–1872. doi: 10.1016/j.neurobiolaging.2014.02.008 PMID:
24656835
15. Yiannakas MC, Kearney H, Samson RS, Chard DT, Ciccarelli O, Miller DH, et al (2012) Feasibility of
grey matter and white matter segmentation of the upper cervical cord in vivo: a pilot study with applica-
tion to magnetisation transfer measurements. Neuroimage 63:1054–9. doi: 10.1016/j.neuroimage.
2012.07.048 PMID: 22850571
16. Samson RS, Ciccarelli O, Kachramanoglou C, Brightman L, Lutti A, Thomas DL, et al (2013) Tissue-
and column-specific measurements frommulti-parameter mapping of the human cervical spinal cord at
3T. NMR Biomed 26:1823–30. doi: 10.1002/nbm.3022 PMID: 24105923
17. El Mendili MM, Cohen-Adad J, Pelegrini-Issac M, Rossignol S, Morizot-Koutlidis R, Marchand-Pauvert
V, et al (2014) Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral
sclerosis. PloS One 9:e95516. doi: 10.1371/journal.pone.0095516 PMID: 24755826
18. Oh J, Saidha S, ChenM, Smith SA, Prince J, Jones C, et al (2013) Spinal cord quantitative MRI discrim-
inates between disability levels in multiple sclerosis. Neurology 80:540–547. doi: 10.1212/WNL.
0b013e31828154c5 PMID: 23325903
19. Oh J, Zackowski K, Chen M, Newsome S, Saidha S, Smith SA, et al. Multiparametric MRI correlates of
sensorimotor function in the spinal cord in multiple sclerosis. Mult Scler 19:427–435. doi: 10.1177/
1352458512456614 PMID: 22891033
20. Zackowski KM, Smith SA, Reich DS, Gordon-Lipkin E, Chodkowski BA, Sambandan DR, et al (2009)
Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging
abnormalities in the spinal cord. Brain 132:1200–1209. doi: 10.1093/brain/awp032 PMID: 19297508
21. Cohen-Adad J, El Mendili MM, Lehericy S Pradat PF, Blancho S, Rossignol S, et al (2011) Demyelin-
ation and degeneration in the injured human spinal cord detected with diffusion and magnetization
transfer MRI. Neuroimage 55:1024–1033. doi: 10.1016/j.neuroimage.2010.11.089 PMID: 21232610
22. Freund P, Weiskopf N, Ashburner J, Wolf K, Sutter R, Altmann DR, et al (2013) MRI investigation of the
sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal
study. Lancet Neurol 12:873–881. doi: 10.1016/S1474-4422(13)70146-7 PMID: 23827394
23. Fowler CJ, Griffiths D, de Groat WC (2008) The neural control of micturition. Nat Rev Neurosci 9:453–
66. doi: 10.1038/nrn2401 PMID: 18490916
24. Yiannakas MC, Kakar P, Hoy LR, Miller DH, Wheeler-Kingshott CA (2014) The Use of the Lumbosacral
Enlargement as an Intrinsic Imaging Biomarker: Feasibility of Grey Matter andWhite Matter Cross-Sec-
tional Area Measurements Using MRI at 3T. PLoS One 9:e105544. doi: 10.1371/journal.pone.
0105544 PMID: 25170763
25. Malas MA, Seker M, Salbacak A, Büyükmumcu M, Karabulut AK, Yardimci C (2000) The relationship
between the lumbosacral enlargement and the conus medullaris during the period of foetal develop-
ment and adulthood. Surgical and Radiology Anatomy 22:163–168.
26. Glover GH, Pauly JM (1992) Projection reconstruction techniques for reduction of motion effects in
MRI. Magn Reson Med 28:275–89. PMID: 1461126
27. Horsfield MA, Sala S, NeemaM, Absinta M, Bakshi A, Sormani MP, et al (2010) Rapid semi-automatic
segmentation of the spinal cord frommagnetic resonance images: application in multiple sclerosis.
Neuroimage 50:446–55. doi: 10.1016/j.neuroimage.2009.12.121 PMID: 20060481
28. Dice LR (1945) Measures of the amount of ecologic association between species. Ecology 26:297–
302.
29. Du Boulay GH (1966) Pulsatile movements in the CSF pathways. Br J Radiol 39:255–62 PMID:
5295581
30. Lane B, Kricheff II (1974) Cerebrospinal fluid pulsations at myelography: a videodensitometric study.
Radiology 110:579–87. PMID: 4811678
31. Wu Y, O’Brien C, Glielmi C, Du H, Edelman R, Ragin A (2010) High Resolution Magnetization Transfer
Imaging at 3T VS. 1.5T. Proc. Intl. Mag. Reson. Med. 18, 4444.
In VivoMTRMeasurements in the Lumbosacral Enlargement
PLOS ONE | DOI:10.1371/journal.pone.0134495 July 31, 2015 9 / 10
32. Gringel T, Schulz-Schaeffer W, Elolf E, Frölich A, Dechent P, Helms G (2009) Optimized high-resolu-
tion mapping of magnetization transfer (MT) at 3 Tesla for direct visualization of substructures of the
human thalamus in clinically feasible measurement time. J Magn Reson Imaging 29:1285–92. doi: 10.
1002/jmri.21756 PMID: 19472385
33. Watanabe T, Vaccaro AR, Kumon H, WelchWC, Rivas DA, Chancellor MB (1998) High incidence of
occult neurogenic bladder dysfunction in neurologically intact patients with thoracolumbar spinal inju-
ries. J Urol 159:965–968. PMID: 9474194
34. Hess MJ, Hough S (2006) Impact of spinal cord injury on sexuality: broad-based clinical practice inter-
vention and practical application. J Spinal Cord Med 35:211–218.
35. Craggs MD, Balasubramaniam AV, Chung EA, Emmanuel AV (2006) Aberrant reflexes and function of
the pelvic organs following spinal cord injury in man. Auton Neurosci 126– 127:355–70.
36. Nout YS, Leedy GM, Beattie MS, Bresnahan JC (2006) Alterations in eliminative and sexual reflexes
after spinal cord injury: defecatory function and development of spasticity in pelvic floor musculature.
Progress in Brain Research 152:359–372. PMID: 16198713
37. Anderson KD, Borisoff JF, Johnson RD, Stiens SA, Elliott SL (2007) The impact of spinal cord injury on
sexual function: concerns of the general population. Spinal Cord 45:328–337. PMID: 17033620
38. Reitz A, Tobe V, Knapp PA, Schurch B (2004) Impact of spinal cord injury on sexual health and quality
of life. Int J Impot Res 16:167–174. PMID: 14973522
39. McCombe PA, Gordon TP, Jackson MW (2009) Bladder dysfunction in multiple sclerosis. Expert Rev
Neurother 9:331–340. doi: 10.1586/14737175.9.3.331 PMID: 19271942
40. Fernandez O (2002) Mechanisms and current treatments of urogenital dysfunction in multiple sclerosis.
J Neurol 249:1–8. PMID: 11954855
41. Sakakibara R, Hattori T, Tojo M, Yamanishi T, Yasuda K, Hirayama K (1993) Micturitional disturbance
in multiple system atrophy. Jpn J Psychiatry Neurol 47:591–598. PMID: 8301874
42. Sakakibara R, Hattori T, Uchiyama T, Kita K, Asahina M, Suzuki A, et al (2000) Urinary dysfunction and
orthostatic hypotension in multiple system atrophy: which is the more common and earlier manifesta-
tion? J Neurol Neurosurg Psychiatry 68:65–69. PMID: 10601404
43. Konno H, Yamamoto T, Iwasaki Y, Iizuka H (1986) Shy-Drager syndrome and amyotrophic lateral scle-
rosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci 73:193–
204. PMID: 3701375
In VivoMTRMeasurements in the Lumbosacral Enlargement
PLOS ONE | DOI:10.1371/journal.pone.0134495 July 31, 2015 10 / 10
